Anoro Ellipta Inhaler 62.5/25MCG

UMECLIDINIUM BROMIDE/VILANTEROL TRIFENATATE


*The product shipped may have different packaging depending on supplier/strength chosen
Anoro Ellipta Inhaler 62.5/25MCG

REQUIRED
UMECLIDINIUM BROMIDE/VILANTEROL TRIFENATATE
Select Strength
Select Quantity
Type
Product
Manufacturer
Country
Qty-price (USD)
Drug:

Anoro Ellipta Inhaler 62.5/25mcg
Manufacturer:
Glaxosmithkline
Approved for Sale in:

New Zealand

Anoro Ellipta Inhaler 62.5/25mcg
Glaxosmithkline

New Zealand
Drug:

Anoro Ellipta Inhaler 62.5/25mcg
Manufacturer:
Glaxosmithkline
Approved for Sale in:

Canada

Anoro Ellipta Inhaler 62.5/25mcg
Glaxosmithkline

Canada
Buy Anoro Ellipta Online | COPD Inhaler 62.5/25 mcg
Anoro Ellipta is a prescription inhaler that combines two long-acting bronchodilators: umeclidinium (62.5 mcg) and vilanterol (25 mcg). Together, they work to relax the muscles around the airways, improving breathing in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema.
Designed for once-daily use, Anoro Ellipta helps reduce symptoms such as shortness of breath, wheezing, and chest tightness. It is not a rescue inhaler and should not be used to treat sudden breathing problems.
Designed for once-daily use, Anoro Ellipta helps reduce symptoms such as shortness of breath, wheezing, and chest tightness. It is not a rescue inhaler and should not be used to treat sudden breathing problems.
Alternative Brands & Comparisons:
- Stiolto Respimat – Tiotropium + olodaterol alternative
- Advair Diskus – For patients needing corticosteroid + LABA
- Trelegy Ellipta – Triple therapy including fluticasone
- Generic umeclidinium/vilanterol – Not yet widely available, but in development
Key Benefits:
- Dual-action bronchodilator for COPD maintenance
- Improves airflow and reduces flare-ups over time
- Once-daily dosing with easy-to-use Ellipta device
- Contains umeclidinium 62.5 mcg + vilanterol 25 mcg
- Available with fast, secure delivery from MailOrderMeds